Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances
Urologic cancers are a heterogeneous group of tumors, some of which have poor prognosis. This is partly due to the unavailability of specific and sensitive diagnostic techniques and monitoring tests, ideally non- or minimally invasive. Hence, liquid biopsies are promising tools that have been gainin...
Saved in:
| Published in: | Cancers Vol. 13; no. 7; p. 1529 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Switzerland
MDPI AG
26-03-2021
MDPI |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Urologic cancers are a heterogeneous group of tumors, some of which have poor prognosis. This is partly due to the unavailability of specific and sensitive diagnostic techniques and monitoring tests, ideally non- or minimally invasive. Hence, liquid biopsies are promising tools that have been gaining significant attention over the last decade. Among the different classes of biomarkers that can be isolated from biofluids, urinary extracellular vesicles (uEVs) are a promising low-invasive source of biomarkers, with the potential to improve cancer diagnosis and disease management. Different techniques have been developed to isolate and characterize the cargo of these vesicles; however, no consensus has been reached, challenging the comparison among studies. This results in a vast number of studies portraying an extensive list of uEV-derived candidate biomarkers for urologic cancers, with the potential to improve clinical outcome; however, without significant validation. Herein, we review the current published research on miRNA and protein-derived uEV for prostate, bladder and kidney cancers, focusing on different uEV isolation methods, and its implications for biomarker studies. |
|---|---|
| AbstractList | Urologic cancers are a heterogeneous group of tumors, some of which have poor prognosis. This is partly due to the unavailability of specific and sensitive diagnostic techniques and monitoring tests, ideally non- or minimally invasive. Hence, liquid biopsies are promising tools that have been gaining significant attention over the last decade. Among the different classes of biomarkers that can be isolated from biofluids, urinary extracellular vesicles (uEVs) are a promising low-invasive source of biomarkers, with the potential to improve cancer diagnosis and disease management. Different techniques have been developed to isolate and characterize the cargo of these vesicles; however, no consensus has been reached, challenging the comparison among studies. This results in a vast number of studies portraying an extensive list of uEV-derived candidate biomarkers for urologic cancers, with the potential to improve clinical outcome; however, without significant validation. Herein, we review the current published research on miRNA and protein-derived uEV for prostate, bladder and kidney cancers, focusing on different uEV isolation methods, and its implications for biomarker studies. Simple SummaryThe diagnostic and monitoring techniques used for urologic cancers comprise a group of invasive methodologies that still lack sensitivity and specificity. Therefore, the search for a non-invasive alternative is of extreme importance. Urinary extracellular vesicles are an emerging source of biomarkers that have the potential to be used in cancer detection and management, in a minimally invasive way. However, the increasing interest, allied to the absence of standardization and consensus in strategies to isolate and characterize these vesicles, results in a vast list of candidate biomarkers that present no significant overlap. In this review, we show the variability in the methods implemented to obtain these vesicles and focus on microRNA and protein-derived urinary extracellular vesicles as candidate biomarkers for prostate, bladder and kidney cancers.AbstractUrologic cancers are a heterogeneous group of tumors, some of which have poor prognosis. This is partly due to the unavailability of specific and sensitive diagnostic techniques and monitoring tests, ideally non- or minimally invasive. Hence, liquid biopsies are promising tools that have been gaining significant attention over the last decade. Among the different classes of biomarkers that can be isolated from biofluids, urinary extracellular vesicles (uEVs) are a promising low-invasive source of biomarkers, with the potential to improve cancer diagnosis and disease management. Different techniques have been developed to isolate and characterize the cargo of these vesicles; however, no consensus has been reached, challenging the comparison among studies. This results in a vast number of studies portraying an extensive list of uEV-derived candidate biomarkers for urologic cancers, with the potential to improve clinical outcome; however, without significant validation. Herein, we review the current published research on miRNA and protein-derived uEV for prostate, bladder and kidney cancers, focusing on different uEV isolation methods, and its implications for biomarker studies. |
| Author | Jerónimo, Carmen Lourenço, Catarina Henrique, Rui Carvalho, Ângela Constâncio, Vera |
| AuthorAffiliation | 4 Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal 3 IPO Porto Research Center (CBEG CI-IPOP), Cancer Biology and Epigenetics Group, Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; vera.salvado.constancio@ipoporto.min-saude.pt (V.C.); rmhenrique@icbas.up.pt (R.H.) 5 Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal 6 Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal 1 i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; clourenco@i3s.up.pt (C.L.); angela.carvalho@ineb.up.pt (Â.C.) 2 INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, |
| AuthorAffiliation_xml | – name: 3 IPO Porto Research Center (CBEG CI-IPOP), Cancer Biology and Epigenetics Group, Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; vera.salvado.constancio@ipoporto.min-saude.pt (V.C.); rmhenrique@icbas.up.pt (R.H.) – name: 4 Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal – name: 6 Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal – name: 1 i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; clourenco@i3s.up.pt (C.L.); angela.carvalho@ineb.up.pt (Â.C.) – name: 5 Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal – name: 2 INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal |
| Author_xml | – sequence: 1 givenname: Catarina orcidid: 0000-0003-0644-0202 surname: Lourenço fullname: Lourenço, Catarina organization: Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal – sequence: 2 givenname: Vera orcidid: 0000-0002-3151-0367 surname: Constâncio fullname: Constâncio, Vera organization: Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal – sequence: 3 givenname: Rui orcidid: 0000-0003-3171-4666 surname: Henrique fullname: Henrique, Rui organization: Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal – sequence: 4 givenname: Ângela orcidid: 0000-0002-4837-6539 surname: Carvalho fullname: Carvalho, Ângela organization: Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal – sequence: 5 givenname: Carmen orcidid: 0000-0003-4186-5345 surname: Jerónimo fullname: Jerónimo, Carmen organization: Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33810357$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkc9PFDEcxRuDEUTO3kwTL14W-mM6nXowWTeAJhA8uF6bTuc7UJxt4duZFf57ulkkQC9t0s_39b2-92QnpgiEfOTsUErDjryLHjBzyTRXwrwhe4JpMatrU-08O--Sg5yvWVlScl3rd2RXyoYzqfQeuVtiiA7v6fHdiM7DMEyDQ_oHcvADZOoy_ZVGiGNwA_0e0srh3_Im7RPSJaYhXQZPF1sjX-k80os14DrAP5p6upgQyyg9h_EqdUUsdnTerTd0_kDe9m7IcPC475PlyfHvxY_Z2cXpz8X8bOYrwcdZ27jaGKMNY61XVcd7xWSlBHQAlfJK697VqlM163RvoPVtD6CcUt4z1Tom98m3re7N1K6g88UPusHeYChR7m1ywb68ieHKXqa1bZism0oUgS-PAphuJ8ijXYW8-SgXIU3ZCsUapYU2sqCfX6HXacJY4hWq0jWvtFCFOtpSHlPOCP2TGc7splj7qtgy8el5hif-f43yAWQgpCY |
| CitedBy_id | crossref_primary_10_2217_epi_2021_0333 crossref_primary_10_3390_cancers14143358 crossref_primary_10_1016_j_jchromb_2023_123828 crossref_primary_10_1038_s41598_024_55781_4 crossref_primary_10_1038_s41598_024_62783_9 crossref_primary_10_3390_cancers13143471 crossref_primary_10_3390_cancers13215429 crossref_primary_10_3390_ijms24076757 crossref_primary_10_3390_cancers15194886 crossref_primary_10_3390_cancers15041307 crossref_primary_10_3390_cancers14030532 crossref_primary_10_3389_fonc_2023_1291177 crossref_primary_10_3390_cancers13174381 crossref_primary_10_3390_jcm10102046 crossref_primary_10_3390_ijms23137134 crossref_primary_10_1016_j_trac_2024_117823 crossref_primary_10_1016_j_ctarc_2022_100677 crossref_primary_10_3389_fmed_2021_800889 crossref_primary_10_3390_cancers13215252 crossref_primary_10_1016_j_seppur_2023_126155 crossref_primary_10_1002_cmdc_202200422 crossref_primary_10_1016_j_semcancer_2022_02_020 crossref_primary_10_1097_MOU_0000000000001194 |
| Cites_doi | 10.1097/MOU.0000000000000078 10.1038/nrurol.2014.301 10.1016/j.euf.2015.11.006 10.1016/j.eururo.2005.04.015 10.18632/oncotarget.8124 10.1158/0008-5472.CAN-18-3538 10.18632/oncotarget.20043 10.1371/journal.pone.0157566 10.1007/s00432-019-03035-6 10.1038/ki.2010.262 10.1016/j.eururo.2016.10.008 10.3390/cancers12061400 10.1016/B978-0-12-816053-4.00002-X 10.3402/jev.v5.31209 10.1371/journal.pone.0215003 10.1002/pmic.201300389 10.1371/journal.pone.0074801 10.1186/s12943-015-0466-2 10.1038/s41598-020-62753-x 10.3390/cells8070727 10.1021/acsnano.6b06131 10.1038/nmeth.4185 10.1515/cclm-2013-0562 10.1146/annurev-cellbio-101512-122326 10.6004/jnccn.2016.0004 10.3892/ol.2014.2373 10.1016/S0094-0143(03)00056-9 10.1073/pnas.0403453101 10.3402/jev.v5.29497 10.1111/cpr.12659 10.1016/j.ejps.2016.09.023 10.1016/j.clinbiochem.2012.11.029 10.1111/jcmm.14553 10.1038/s41551-019-0356-9 10.1016/j.bios.2016.12.062 10.1038/s41585-019-0261-8 10.1039/C4LC00136B 10.1158/0008-5472.CAN-17-0994 10.1016/j.eururo.2016.05.041 10.3402/jev.v2i0.21494 10.1080/20013078.2018.1535750 10.1016/j.nano.2011.04.003 10.1038/srep42961 10.1038/sj.ki.5000273 10.1016/j.eururo.2016.02.046 10.1038/ki.2012.256 10.1002/pros.23934 10.1002/pros.23295 10.18632/oncotarget.14969 10.1016/j.ejps.2016.10.008 10.1021/pr3008732 10.1016/j.juro.2012.04.143 10.1021/pr700775x 10.1016/j.ctarc.2020.100195 10.3390/ijms21218330 10.1038/ki.2009.550 10.1021/acs.jproteome.7b00763 10.1002/prca.200800093 10.1093/annonc/mdv222 10.1093/ndt/gfn058 10.1016/j.procbio.2019.09.017 10.1038/nrurol.2016.224 10.1016/j.ymeth.2012.01.002 10.1038/ncb1596 10.18632/oncotarget.4851 10.1080/20013078.2020.1736935 10.1016/j.mric.2014.01.002 10.1039/C8LC00834E 10.1155/2018/8545347 10.1016/j.eururo.2015.07.072 10.1016/j.bbagen.2016.07.028 10.1016/j.eururo.2011.07.066 10.1152/ajprenal.00128.2014 10.1039/C4LC00662C 10.1007/s00216-019-01982-0 10.4103/0970-1591.166445 10.1111/nep.12867 10.1007/978-1-4939-7253-1_18 10.14740/wjon1279 10.5772/62579 10.1002/pros.23376 10.3402/jev.v4.27369 10.3322/caac.21492 10.3390/bioengineering6010007 10.1016/j.mcna.2020.08.007 10.1038/ki.2013.502 10.1039/c3mb25582d 10.3389/fonc.2020.00724 10.1021/acsnano.7b04878 10.1038/s41598-018-22142-x 10.1080/14737159.2019.1604224 10.1371/annotation/9281c713-d253-4a1a-8255-92e691e77a24 10.3389/fonc.2020.582843 10.1016/j.urology.2014.02.013 10.1152/ajprenal.00434.2006 10.20944/preprints201810.0507.v1 10.1016/j.jbiotec.2017.07.029 10.18632/oncotarget.13634 |
| ContentType | Journal Article |
| Copyright | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
| Copyright_xml | – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
| DBID | NPM AAYXX CITATION 3V. 7T5 7TO 7XB 8FE 8FH 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ GUQSH H94 HCIFZ LK8 M2O M7P MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.3390/cancers13071529 |
| DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Oncogenes and Growth Factors Abstracts ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection Biological Sciences Research Library Biological Science Database Research Library (Corporate) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database PubMed |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2072-6694 |
| ExternalDocumentID | 10_3390_cancers13071529 33810357 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: Fundação para a Ciência e a Tecnologia grantid: PTDC/BTM-TEC/30831/2017 – fundername: Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona grantid: LCF/BQ/DR20/11790013 – fundername: Fundação para a Ciência e a Tecnologia grantid: POCI-01-0145-FEDER-030831 – fundername: Instituto Português de Oncologia do Porto grantid: CI-IPOP-PI27-FB-GEBC |
| GroupedDBID | --- 3V. 53G 5VS 8FE 8FH 8G5 AADQD AAFWJ ABDBF ABUWG ADBBV AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU DIK DWQXO E3Z EBD ESX GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HYE IAO IHR ITC KQ8 LK8 M2O M48 M7P MODMG M~E NPM OK1 P6G PGMZT PIMPY PQQKQ PROAC RIG RPM TUS AAYXX CITATION 7T5 7TO 7XB 8FK H94 MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM AFPKN |
| ID | FETCH-LOGICAL-c421t-b8a69997900bc54d1f503452edee45c577fa65d560d7f9ebcbfee5a55cc05ba03 |
| IEDL.DBID | RPM |
| ISSN | 2072-6694 |
| IngestDate | Tue Sep 17 21:17:32 EDT 2024 Fri Oct 25 10:50:57 EDT 2024 Thu Oct 10 16:58:22 EDT 2024 Fri Nov 22 02:54:28 EST 2024 Wed Oct 16 00:43:37 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | urologic cancers liquid biopsies miRNA and protein biomarkers minimally-invasive biomarkers urinary extracellular vesicles |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c421t-b8a69997900bc54d1f503452edee45c577fa65d560d7f9ebcbfee5a55cc05ba03 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 These authors contributed equally to this paper. |
| ORCID | 0000-0003-0644-0202 0000-0003-3171-4666 0000-0002-3151-0367 0000-0002-4837-6539 0000-0003-4186-5345 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036842/ |
| PMID | 33810357 |
| PQID | 2547614725 |
| PQPubID | 2032421 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8036842 proquest_miscellaneous_2508572793 proquest_journals_2547614725 crossref_primary_10_3390_cancers13071529 pubmed_primary_33810357 |
| PublicationCentury | 2000 |
| PublicationDate | 20210326 |
| PublicationDateYYYYMMDD | 2021-03-26 |
| PublicationDate_xml | – month: 3 year: 2021 text: 20210326 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Cancers |
| PublicationTitleAlternate | Cancers (Basel) |
| PublicationYear | 2021 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Sullivan (ref_92) 2015; 7 Hattori (ref_10) 2014; 83 He (ref_48) 2014; 14 ref_12 ref_11 Lin (ref_88) 2016; 6 Gonzales (ref_14) 2008; 23 Merchant (ref_40) 2010; 4 Smalley (ref_85) 2008; 7 Linxweiler (ref_99) 2020; 17 Zhang (ref_50) 2019; 3 Babjuk (ref_83) 2017; 71 ref_15 Hessvik (ref_75) 2017; 16 Andreu (ref_87) 2017; 98 Wani (ref_74) 2017; 259 Padala (ref_96) 2020; 11 Valadi (ref_21) 2007; 9 Cho (ref_34) 2020; 88 Verma (ref_3) 2014; 22 ref_24 Ogawa (ref_81) 2020; 24 ref_22 Liang (ref_19) 2017; 7 Mossanen (ref_82) 2014; 24 Lee (ref_60) 2018; 41 Chen (ref_86) 2012; 11 ref_72 Ruivo (ref_17) 2017; 77 Wang (ref_70) 2017; 98 Armstrong (ref_91) 2015; 14 ref_78 Salih (ref_103) 2014; 306 ref_77 Henrique (ref_7) 2019; 19 Bancu (ref_41) 2015; 4 Fujita (ref_68) 2017; 7 Janzen (ref_101) 2003; 30 Hisey (ref_47) 2018; 18 Colombo (ref_58) 2014; 30 ref_84 Raimondo (ref_104) 2013; 9 Alvarez (ref_28) 2012; 82 Cheruvanky (ref_39) 2007; 292 Xu (ref_73) 2017; 77 Bouzo (ref_23) 2019; 17 Mestdagh (ref_25) 2017; 14 Junker (ref_18) 2016; 70 McNicholas (ref_56) 2017; 22 Kanwar (ref_45) 2014; 14 Craven (ref_102) 2013; 46 ref_57 Tauro (ref_38) 2012; 56 Qin (ref_95) 2020; 10 Katsuda (ref_20) 2014; 14 Blecher (ref_5) 2019; 37 Cizmar (ref_53) 2017; 1660 Baumgart (ref_94) 2019; 145 Hsieh (ref_100) 2017; 3 Khositseth (ref_26) 2010; 77 Matsuzaki (ref_93) 2017; 8 Dhondt (ref_35) 2020; 9 Gheinani (ref_32) 2018; 8 ref_63 Song (ref_106) 2019; 23 Rupert (ref_52) 2017; 1861 Parker (ref_62) 2020; 26 Woo (ref_51) 2017; 11 Nawaz (ref_42) 2014; 11 Liu (ref_46) 2017; 11 Dragovic (ref_55) 2011; 7 Bray (ref_1) 2018; 68 Dorayappan (ref_49) 2019; 79 Yuana (ref_54) 2013; 2 Hackenberg (ref_71) 2016; 7 Zhou (ref_107) 2006; 69 He (ref_33) 2019; 43 DeGeorge (ref_4) 2017; 96 Dy (ref_6) 2017; 71 Mohler (ref_61) 2016; 14 Wachalska (ref_31) 2016; 5 Truong (ref_9) 2013; 189 ref_36 Isharwal (ref_79) 2015; 31 Gholizadeh (ref_43) 2017; 91 Rood (ref_27) 2010; 78 Sequeiros (ref_69) 2017; 8 Hou (ref_44) 2019; 411 Butz (ref_105) 2016; 2 Wu (ref_59) 2019; 52 Nuhn (ref_80) 2012; 61 Gorin (ref_8) 2017; 14 Foj (ref_76) 2017; 77 Channavajjhala (ref_29) 2014; 52 Roddam (ref_64) 2005; 48 Overbye (ref_66) 2015; 6 Lakshminarayanan (ref_98) 2020; 10 Pisitkun (ref_13) 2004; 101 Zhang (ref_37) 2014; 8 Witwer (ref_16) 2018; 7 Hiltbrunner (ref_90) 2020; 10 Cheng (ref_109) 2014; 86 Silvers (ref_89) 2017; 8 Raimondo (ref_108) 2018; 17 ref_2 Marconi (ref_97) 2016; 69 Miyahira (ref_65) 2020; 80 Royo (ref_30) 2016; 5 Welton (ref_67) 2016; 5 |
| References_xml | – volume: 24 start-page: 487 year: 2014 ident: ref_82 article-title: The burden of bladder cancer care: Direct and indirect costs publication-title: Curr. Opin. Urol. doi: 10.1097/MOU.0000000000000078 contributor: fullname: Mossanen – volume: 11 start-page: 688 year: 2014 ident: ref_42 article-title: The emerging role of extracellular vesicles as biomarkers for urogenital cancers publication-title: Nat. Rev. Urol. doi: 10.1038/nrurol.2014.301 contributor: fullname: Nawaz – volume: 2 start-page: 210 year: 2016 ident: ref_105 article-title: Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma publication-title: Eur. Urol. Focus doi: 10.1016/j.euf.2015.11.006 contributor: fullname: Butz – volume: 48 start-page: 386 year: 2005 ident: ref_64 article-title: Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/mL: Systematic review and meta-analysis publication-title: Eur. Urol. doi: 10.1016/j.eururo.2005.04.015 contributor: fullname: Roddam – volume: 7 start-page: 22566 year: 2016 ident: ref_71 article-title: Non—Invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles publication-title: Oncotarget doi: 10.18632/oncotarget.8124 contributor: fullname: Hackenberg – volume: 7 start-page: 2500 year: 2015 ident: ref_92 article-title: A non-invasive miRNA based assay to detect bladder cancer in cell-free urine publication-title: Am. J. Transl. Res. contributor: fullname: Sullivan – volume: 79 start-page: 3503 year: 2019 ident: ref_49 article-title: A microfluidic chip enables isolation of exosomes and establishment of their protein profiles and associated signaling pathways in ovarian cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-3538 contributor: fullname: Dorayappan – volume: 8 start-page: 91199 year: 2017 ident: ref_89 article-title: Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer publication-title: Oncotarget doi: 10.18632/oncotarget.20043 contributor: fullname: Silvers – ident: ref_72 doi: 10.1371/journal.pone.0157566 – volume: 145 start-page: 2725 year: 2019 ident: ref_94 article-title: MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-019-03035-6 contributor: fullname: Baumgart – volume: 78 start-page: 810 year: 2010 ident: ref_27 article-title: Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome publication-title: Kidney Int. doi: 10.1038/ki.2010.262 contributor: fullname: Rood – volume: 71 start-page: 437 year: 2017 ident: ref_6 article-title: Global Burden of Urologic Cancers, 1990–2013 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2016.10.008 contributor: fullname: Dy – ident: ref_84 doi: 10.3390/cancers12061400 – ident: ref_36 doi: 10.1016/B978-0-12-816053-4.00002-X – volume: 5 start-page: 31209 year: 2016 ident: ref_67 article-title: Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array publication-title: J. Extracell. Vesicles doi: 10.3402/jev.v5.31209 contributor: fullname: Welton – ident: ref_77 doi: 10.1371/journal.pone.0215003 – volume: 14 start-page: 412 year: 2014 ident: ref_20 article-title: The roles of extracellular vesicles in cancer biology: Toward the development of novel cancer biomarkers publication-title: Proteomics doi: 10.1002/pmic.201300389 contributor: fullname: Katsuda – ident: ref_24 doi: 10.1371/journal.pone.0074801 – volume: 14 start-page: 1 year: 2015 ident: ref_91 article-title: MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer publication-title: Mol. Cancer doi: 10.1186/s12943-015-0466-2 contributor: fullname: Armstrong – volume: 96 start-page: 507 year: 2017 ident: ref_4 article-title: Bladder Cancer: Diagnosis and Treatment publication-title: Am. Fam. Phys. contributor: fullname: DeGeorge – volume: 10 start-page: 1 year: 2020 ident: ref_90 article-title: Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging publication-title: Sci. Rep. doi: 10.1038/s41598-020-62753-x contributor: fullname: Hiltbrunner – ident: ref_15 doi: 10.3390/cells8070727 – volume: 11 start-page: 1360 year: 2017 ident: ref_51 article-title: Exodisc for Rapid, Size-Selective, and Efficient Isolation and Analysis of Nanoscale Extracellular Vesicles from Biological Samples publication-title: ACS Nano doi: 10.1021/acsnano.6b06131 contributor: fullname: Woo – volume: 14 start-page: 228 year: 2017 ident: ref_25 article-title: EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research publication-title: Nat. Methods doi: 10.1038/nmeth.4185 contributor: fullname: Mestdagh – volume: 52 start-page: 345 year: 2014 ident: ref_29 article-title: Optimizing the purification and analysis of miRNAs from urinary exosomes publication-title: Clin. Chem. Lab. Med. doi: 10.1515/cclm-2013-0562 contributor: fullname: Channavajjhala – volume: 30 start-page: 255 year: 2014 ident: ref_58 article-title: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles publication-title: Annu. Rev. Cell Dev. Biol. doi: 10.1146/annurev-cellbio-101512-122326 contributor: fullname: Colombo – volume: 14 start-page: 19 year: 2016 ident: ref_61 article-title: Prostate Cancer, Version 1.2016 publication-title: J. Natl. Compr. Cancer Netw. doi: 10.6004/jnccn.2016.0004 contributor: fullname: Mohler – volume: 8 start-page: 1701 year: 2014 ident: ref_37 article-title: Comparison of ultracentrifugation and density gradient separation methods for isolating Tca8113 human tongue cancer cell line-derived exosomes publication-title: Oncol. Lett. doi: 10.3892/ol.2014.2373 contributor: fullname: Zhang – volume: 30 start-page: 843 year: 2003 ident: ref_101 article-title: Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease publication-title: Urol. Clin. N. Am. doi: 10.1016/S0094-0143(03)00056-9 contributor: fullname: Janzen – volume: 43 start-page: 83 year: 2019 ident: ref_33 article-title: A highly efficient method for isolating urinary exosomes publication-title: Int. J. Mol. Med. contributor: fullname: He – volume: 101 start-page: 13368 year: 2004 ident: ref_13 article-title: Identification and proteomic profiling of exosomes in human urine publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0403453101 contributor: fullname: Pisitkun – volume: 5 start-page: 29497 year: 2016 ident: ref_30 article-title: Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples publication-title: J. Extracell. Vesicles doi: 10.3402/jev.v5.29497 contributor: fullname: Royo – volume: 41 start-page: 179 year: 2018 ident: ref_60 article-title: Altered proteome of extracellular vesicles derived from bladder cancer patients urine publication-title: Mol. Cells contributor: fullname: Lee – volume: 52 start-page: e12659 year: 2019 ident: ref_59 article-title: Extracellular vesicles in urologic malignancies—Implementations for future cancer care publication-title: Cell Prolif. doi: 10.1111/cpr.12659 contributor: fullname: Wu – volume: 98 start-page: 80 year: 2017 ident: ref_70 article-title: Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2016.09.023 contributor: fullname: Wang – volume: 46 start-page: 456 year: 2013 ident: ref_102 article-title: Proteomics and the search for biomarkers for renal cancer publication-title: Clin. Biochem. doi: 10.1016/j.clinbiochem.2012.11.029 contributor: fullname: Craven – volume: 23 start-page: 6755 year: 2019 ident: ref_106 article-title: Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5 publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.14553 contributor: fullname: Song – volume: 3 start-page: 438 year: 2019 ident: ref_50 article-title: Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip publication-title: Nat. Biomed. Eng. doi: 10.1038/s41551-019-0356-9 contributor: fullname: Zhang – volume: 91 start-page: 588 year: 2017 ident: ref_43 article-title: Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: Current status and future directions publication-title: Biosens. Bioelectron. doi: 10.1016/j.bios.2016.12.062 contributor: fullname: Gholizadeh – volume: 17 start-page: 11 year: 2020 ident: ref_99 article-title: Extracellular vesicles in urological malignancies: An update publication-title: Nat. Rev. Urol. doi: 10.1038/s41585-019-0261-8 contributor: fullname: Linxweiler – volume: 14 start-page: 1891 year: 2014 ident: ref_45 article-title: Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes publication-title: Lab Chip doi: 10.1039/C4LC00136B contributor: fullname: Kanwar – volume: 6 start-page: 1 year: 2016 ident: ref_88 article-title: Proteome profiling of urinary exosomes identifies alpha 1-antitrypsin and H2B1K as diagnostic and prognostic biomarkers for urothelial carcinoma publication-title: Sci. Rep. contributor: fullname: Lin – volume: 77 start-page: 6480 year: 2017 ident: ref_17 article-title: The biology of cancer exosomes: Insights and new perspectives publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-0994 contributor: fullname: Ruivo – volume: 3 start-page: 1 year: 2017 ident: ref_100 article-title: Renal cell carcinoma publication-title: Nat. Rev. Dis. Prim. contributor: fullname: Hsieh – volume: 71 start-page: 447 year: 2017 ident: ref_83 article-title: EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2016.05.041 contributor: fullname: Babjuk – volume: 2 start-page: 21494 year: 2013 ident: ref_54 article-title: Cryo-electron microscopy of extracellular vesicles in fresh plasma publication-title: J. Extracell. Vesicles doi: 10.3402/jev.v2i0.21494 contributor: fullname: Yuana – volume: 7 start-page: 1535750 year: 2018 ident: ref_16 article-title: Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines publication-title: J. Extracell. Vesicles doi: 10.1080/20013078.2018.1535750 contributor: fullname: Witwer – volume: 7 start-page: 780 year: 2011 ident: ref_55 article-title: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis publication-title: Nanomedicine doi: 10.1016/j.nano.2011.04.003 contributor: fullname: Dragovic – volume: 7 start-page: 1 year: 2017 ident: ref_68 article-title: Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer publication-title: Sci. Rep. doi: 10.1038/srep42961 contributor: fullname: Fujita – volume: 69 start-page: 1471 year: 2006 ident: ref_107 article-title: Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery publication-title: Kidney Int. doi: 10.1038/sj.ki.5000273 contributor: fullname: Zhou – volume: 70 start-page: 323 year: 2016 ident: ref_18 article-title: Extracellular Vesicles and Their Role in Urologic Malignancies publication-title: Eur. Urol. doi: 10.1016/j.eururo.2016.02.046 contributor: fullname: Junker – volume: 82 start-page: 1024 year: 2012 ident: ref_28 article-title: Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers publication-title: Kidney Int. doi: 10.1038/ki.2012.256 contributor: fullname: Alvarez – volume: 80 start-page: 113 year: 2020 ident: ref_65 article-title: Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting publication-title: Prostate doi: 10.1002/pros.23934 contributor: fullname: Miyahira – volume: 77 start-page: 573 year: 2017 ident: ref_76 article-title: Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis publication-title: Prostate doi: 10.1002/pros.23295 contributor: fullname: Foj – volume: 8 start-page: 24668 year: 2017 ident: ref_93 article-title: MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma publication-title: Oncotarget doi: 10.18632/oncotarget.14969 contributor: fullname: Matsuzaki – volume: 98 start-page: 70 year: 2017 ident: ref_87 article-title: Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2016.10.008 contributor: fullname: Andreu – volume: 11 start-page: 5611 year: 2012 ident: ref_86 article-title: Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients publication-title: J. Proteome Res. doi: 10.1021/pr3008732 contributor: fullname: Chen – volume: 189 start-page: 422 year: 2013 ident: ref_9 article-title: Toward the detection of prostate cancer in urine: A critical analysis publication-title: J. Urol. doi: 10.1016/j.juro.2012.04.143 contributor: fullname: Truong – volume: 7 start-page: 2088 year: 2008 ident: ref_85 article-title: Isolation and identification of potential urinary microparticle biomarkers of bladder cancer publication-title: J. Proteome Res. doi: 10.1021/pr700775x contributor: fullname: Smalley – volume: 24 start-page: 100195 year: 2020 ident: ref_81 article-title: Prognosis of patients with muscle invasive bladder cancer who are intolerable to receive any anti-cancer treatment publication-title: Cancer Treat. Res. Commun. doi: 10.1016/j.ctarc.2020.100195 contributor: fullname: Ogawa – ident: ref_78 doi: 10.3390/ijms21218330 – volume: 16 start-page: 4 year: 2017 ident: ref_75 article-title: Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes publication-title: Mol. Cancer contributor: fullname: Hessvik – volume: 17 start-page: 1 year: 2019 ident: ref_23 article-title: Exosome-mimetic nanoplatforms for targeted cancer drug delivery publication-title: J. Nanobiotechnol. contributor: fullname: Bouzo – volume: 77 start-page: 736 year: 2010 ident: ref_26 article-title: Tamm-Horsfall protein and urinary exosome isolation publication-title: Kidney Int. doi: 10.1038/ki.2009.550 contributor: fullname: Khositseth – volume: 17 start-page: 2572 year: 2018 ident: ref_108 article-title: Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges publication-title: J. Proteome Res. doi: 10.1021/acs.jproteome.7b00763 contributor: fullname: Raimondo – volume: 4 start-page: 84 year: 2010 ident: ref_40 article-title: Microfiltration isolation of human urinary exosomes for characterization by MS publication-title: Proteom. Clin. Appl. doi: 10.1002/prca.200800093 contributor: fullname: Merchant – volume: 26 start-page: v69 year: 2020 ident: ref_62 article-title: Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† publication-title: Ann. Oncol. doi: 10.1093/annonc/mdv222 contributor: fullname: Parker – volume: 23 start-page: 1799 year: 2008 ident: ref_14 article-title: Urinary exosomes: Is there a future? publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfn058 contributor: fullname: Gonzales – volume: 88 start-page: 197 year: 2020 ident: ref_34 article-title: Development and comparative analysis of human urine exosome isolation strategies publication-title: Process Biochem. doi: 10.1016/j.procbio.2019.09.017 contributor: fullname: Cho – volume: 14 start-page: 90 year: 2017 ident: ref_8 article-title: Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer publication-title: Nat. Rev. Urol. doi: 10.1038/nrurol.2016.224 contributor: fullname: Gorin – volume: 56 start-page: 293 year: 2012 ident: ref_38 article-title: Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes publication-title: Methods doi: 10.1016/j.ymeth.2012.01.002 contributor: fullname: Tauro – volume: 9 start-page: 654 year: 2007 ident: ref_21 article-title: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells publication-title: Nat. Cell Biol. doi: 10.1038/ncb1596 contributor: fullname: Valadi – volume: 6 start-page: 30357 year: 2015 ident: ref_66 article-title: Identification of prostate cancer biomarkers in urinary exosomes publication-title: Oncotarget doi: 10.18632/oncotarget.4851 contributor: fullname: Overbye – volume: 9 start-page: 1736935 year: 2020 ident: ref_35 article-title: Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine publication-title: J. Extracell. Vesicles doi: 10.1080/20013078.2020.1736935 contributor: fullname: Dhondt – volume: 22 start-page: 135 year: 2014 ident: ref_3 article-title: MR imaging-guided prostate biopsy techniques publication-title: Magn. Reson. Imaging Clin. N. Am. doi: 10.1016/j.mric.2014.01.002 contributor: fullname: Verma – volume: 37 start-page: 508 year: 2019 ident: ref_5 article-title: Renal cancer publication-title: Surg. Oxf. Int. Ed. contributor: fullname: Blecher – volume: 18 start-page: 3144 year: 2018 ident: ref_47 article-title: Microfluidic affinity separation chip for selective capture and release of label-free ovarian cancer exosomes publication-title: Lab Chip doi: 10.1039/C8LC00834E contributor: fullname: Hisey – ident: ref_12 doi: 10.1155/2018/8545347 – volume: 69 start-page: 660 year: 2016 ident: ref_97 article-title: Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy publication-title: Eur. Urol. doi: 10.1016/j.eururo.2015.07.072 contributor: fullname: Marconi – volume: 1861 start-page: 3164 year: 2017 ident: ref_52 article-title: Methods for the physical characterization and quantification of extracellular vesicles in biological samples publication-title: Biochim. Biophys. Acta Gen. Subj. doi: 10.1016/j.bbagen.2016.07.028 contributor: fullname: Rupert – volume: 61 start-page: 58 year: 2012 ident: ref_80 article-title: External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder publication-title: Eur. Urol. doi: 10.1016/j.eururo.2011.07.066 contributor: fullname: Nuhn – volume: 306 start-page: F1251 year: 2014 ident: ref_103 article-title: Urinary extracellular vesicles and the kidney: Biomarkers and beyond publication-title: Am. J. Physiol. Ren. Physiol. doi: 10.1152/ajprenal.00128.2014 contributor: fullname: Salih – volume: 14 start-page: 3773 year: 2014 ident: ref_48 article-title: Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology publication-title: Lab Chip doi: 10.1039/C4LC00662C contributor: fullname: He – volume: 411 start-page: 5351 year: 2019 ident: ref_44 article-title: Advances in exosome isolation methods and their applications in proteomic analysis of biological samples publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-019-01982-0 contributor: fullname: Hou – volume: 31 start-page: 289 year: 2015 ident: ref_79 article-title: Non-muscle invasive bladder cancer risk stratification publication-title: Indian J. Urol. doi: 10.4103/0970-1591.166445 contributor: fullname: Isharwal – volume: 22 start-page: 854 year: 2017 ident: ref_56 article-title: Albuminuria is not associated with elevated urinary vesicle concentration but can confound nanoparticle tracking analysis publication-title: Nephrology doi: 10.1111/nep.12867 contributor: fullname: McNicholas – volume: 1660 start-page: 221 year: 2017 ident: ref_53 article-title: Detection and Characterization of Extracellular Vesicles by Transmission and Cryo-Transmission Electron Microscopy publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-7253-1_18 contributor: fullname: Cizmar – volume: 11 start-page: 79 year: 2020 ident: ref_96 article-title: Epidemiology of Renal Cell Carcinoma publication-title: World J. Oncol. doi: 10.14740/wjon1279 contributor: fullname: Padala – volume: 5 start-page: 4 year: 2016 ident: ref_31 article-title: Protein Complexes in Urine Interfere with Extracellular Vesicle Biomarker Studies publication-title: J. Circ. Biomark. doi: 10.5772/62579 contributor: fullname: Wachalska – volume: 77 start-page: 1167 year: 2017 ident: ref_73 article-title: MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method publication-title: Prostate doi: 10.1002/pros.23376 contributor: fullname: Xu – volume: 4 start-page: 27369 year: 2015 ident: ref_41 article-title: Size-exclusion chromatography-based enrichment of extracellular vesicles from urine samples publication-title: J. Extracell. Vesicles doi: 10.3402/jev.v4.27369 contributor: fullname: Bancu – volume: 68 start-page: 394 year: 2018 ident: ref_1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: Cancer J. Clin. doi: 10.3322/caac.21492 contributor: fullname: Bray – ident: ref_57 doi: 10.3390/bioengineering6010007 – volume: 7 start-page: 1 year: 2017 ident: ref_19 article-title: An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer publication-title: Sci. Rep. contributor: fullname: Liang – ident: ref_63 doi: 10.1016/j.mcna.2020.08.007 – volume: 86 start-page: 433 year: 2014 ident: ref_109 article-title: Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine publication-title: Kidney Int. doi: 10.1038/ki.2013.502 contributor: fullname: Cheng – volume: 9 start-page: 1220 year: 2013 ident: ref_104 article-title: Differential protein profiling of renal cell carcinoma urinary exosomes publication-title: Mol. Biosyst. doi: 10.1039/c3mb25582d contributor: fullname: Raimondo – volume: 10 start-page: 724 year: 2020 ident: ref_95 article-title: Extracellular Vesicles in Renal Cell Carcinoma: Multifaceted Roles and Potential Applications Identified by Experimental and Computational Methods publication-title: Front. Oncol. doi: 10.3389/fonc.2020.00724 contributor: fullname: Qin – volume: 11 start-page: 10712 year: 2017 ident: ref_46 article-title: The Exosome Total Isolation Chip publication-title: ACS Nano doi: 10.1021/acsnano.7b04878 contributor: fullname: Liu – volume: 8 start-page: 1 year: 2018 ident: ref_32 article-title: Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery publication-title: Sci. Rep. doi: 10.1038/s41598-018-22142-x contributor: fullname: Gheinani – volume: 19 start-page: 367 year: 2019 ident: ref_7 article-title: Known epigenetic biomarkers for prostate cancer detection and management: Exploring the potential of blood-based liquid biopsies publication-title: Expert Rev. Mol. Diagn. doi: 10.1080/14737159.2019.1604224 contributor: fullname: Henrique – ident: ref_11 doi: 10.1371/annotation/9281c713-d253-4a1a-8255-92e691e77a24 – volume: 10 start-page: 2302 year: 2020 ident: ref_98 article-title: Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease publication-title: Front. Oncol. doi: 10.3389/fonc.2020.582843 contributor: fullname: Lakshminarayanan – ident: ref_2 – volume: 83 start-page: 1443.e9 year: 2014 ident: ref_10 article-title: Detection of bladder cancer by measuring CD44v6 expression in urine with real-time quantitative reverse transcription polymerase chain reaction publication-title: Urology doi: 10.1016/j.urology.2014.02.013 contributor: fullname: Hattori – volume: 292 start-page: F1657 year: 2007 ident: ref_39 article-title: Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator publication-title: Am. J. Physiol. Ren. Physiol. doi: 10.1152/ajprenal.00434.2006 contributor: fullname: Cheruvanky – ident: ref_22 doi: 10.20944/preprints201810.0507.v1 – volume: 259 start-page: 135 year: 2017 ident: ref_74 article-title: Urinary-exosomal miR-2909: A novel pathognomonic trait of prostate cancer severity publication-title: J. Biotechnol. doi: 10.1016/j.jbiotec.2017.07.029 contributor: fullname: Wani – volume: 8 start-page: 4960 year: 2017 ident: ref_69 article-title: Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer publication-title: Oncotarget doi: 10.18632/oncotarget.13634 contributor: fullname: Sequeiros |
| SSID | ssj0000331767 |
| Score | 2.3914897 |
| SecondaryResourceType | review_article |
| Snippet | Urologic cancers are a heterogeneous group of tumors, some of which have poor prognosis. This is partly due to the unavailability of specific and sensitive... Simple SummaryThe diagnostic and monitoring techniques used for urologic cancers comprise a group of invasive methodologies that still lack sensitivity and... |
| SourceID | pubmedcentral proquest crossref pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | 1529 |
| SubjectTerms | Biomarkers Biopsy Extracellular vesicles Kidneys Methods miRNA Morbidity Mortality Prostate Prostate cancer Proteins Review Standardization Tumors Urine |
| Title | Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33810357 https://www.proquest.com/docview/2547614725 https://search.proquest.com/docview/2508572793 https://pubmed.ncbi.nlm.nih.gov/PMC8036842 |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwEB3RPSAuiG8CCzISBy7ZpnFsJ9xK6WovhZWgiFvkr4hK22SVtLA_nxknqbrLjXNsx_HYM2-c52eA98rpTPrMxkJbF2czL-PC5ySvrWWOC53rsKd78U19-Zl_XpJMjhjPwgTSvjWbs_pqe1ZvfgVu5fXWTkee2PRytcjR7eZZOp3ABLHhUYoe3C_HkChVL-PDMaWfWhq_tkNvrTBakU4oJ10rTiHpOBj9gzDvEiWPIs_5I3g4QEY277v2GO75-gncXw0_xZ_CzboNh2rZ8gar0048UUvZD9-FT2G6Y5fNjlhB2MqnTbMlRk7bMYSrbN32zo8t-t5_ZPOaff1NDsT_YU3FBv0mtgo3TWNjtWPznjfQPYP1-fL74iIeLlSIbZbOdrHJtURAqIokMVZkblaJhGci9c77TFihVKWlcAiCnKoKb6ypvBdaCGsTYXTCn8NJ3dT-JTBbVEbOpCi0QYBgXM5zxy2iF-8rizl3BB_GkS2ve92MEvMNskd5xx4RnI4jXw4LqCsxb1WIHFQqInh3eIxTn0ZR177ZUxmS50_Rw0TwojfU4V2jhSNQt0x4KECy2ref4GwL8trD7Hr13zVfw4OUmC8Jj1N5Cie7du_fwKRz-7dhqv4F_hfzMg |
| link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH5iQ4JdGD-3sAFG4sAlaxrHdsKtlE5FrGMSK-IW-VdEpTWZkhb25_PsJFU3bjvbsRM_-73vOZ8_A3wQRibcJjpkUpswGVoeZjZ18tqSp7jQqfR7utMf4vxX-mXiZHJYfxbGk_a1WpyUV8uTcvHbcyuvl3rQ88QGF7Nxim43TeLBDjzE9RpFW0m6d8AUgyIXrZAPxaR-oN0I1g36a4HxyimFUqdsRV1Q2g5H_2HMu1TJrdhzun_Pt34KTzqwSUZt8TN4YMvn8GjW_U5_ATfz2h_HJZMb7Nbt4TtSKvlpG98ckQ25qFaOT4StfF5US8flqRuCQJfM69ZtknH71Z_IqCTf_zjXY_-SqiCd8hOZ-TuqsbHSkFHLOGhewvx0cjmeht1VDKFO4uEqVKnkCCVFFkVKs8QMCxbRhMXWWJswzYQoJGcG4ZMRRWaVVoW1TDKmdcSUjOgr2C2r0h4C0Vmh-JCzTCqEFsqkNDVUI-6xttCYrQfwsbdIft0qbuSYqTg75nfsGMBxb7G8W3pNjhmvQMwhYhbA-00xLho3irK01drVccL-MfqmAA5aA2_66mdGAOKW6TcVnCD37RK0uBfm7iz8-t5PvoPH08vZWX729fzbEezFjj8T0TDmx7C7qtf2Dew0Zv3WT_d_kXgIyA |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9MwGH7FhjRx4ZsRGGAkDlyypHFsJ9xK12oIOipBEbfIXxGVaFIl7bafz2snrbpxg3McO_Hj98t58hjgnTAy5TbVIZPahOnA8jC3mZPXljxDQ6fS7-mefxMXP7OzsZPJ2R315Un7Wi1Oq9_L02rxy3MrV0sdbXli0Ww6ytDtZmkSrUwZHcBdtNk42SvUvROmGBi56MR8KBb2kXaz2LToswXGLKcWSp26FXWBaT8k_ZVn3qZL7sWfyYP_ePKHcL9POsmwa_II7tjqMRxN-8_qT-B63vjfcsn4God2e_mOnEp-2NZ3SWRLZvXa8Yqwl4-Leuk4PU1LMOEl86Zzn2TUvfkHMqzI10vnguwVqUvSK0CRqT-rGjurDBl2zIP2Kcwn4--j87A_kiHUaTJYhyqTHFNKkcex0iw1g5LFNGWJNdamTDMhSsmZwTTKiDK3SqvSWiYZ0zpmSsb0GRxWdWWfA9F5qfiAs1wqTDGUyWhmqMb8x9pSY9UewPstKsWqU94osGJxWBa3sAzgZIta0ZtgW2DlKzD3EAkL4O3uMhqPm0VZ2Xrj2jiB_wR9VADHHci7sbarIwBxA_5dAyfMffMKou4FunuUX_zznW_gaHY2Kb58uvj8Eu4ljkYT0zDhJ3C4bjb2FRy0ZvPar_g_zR4LSA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urinary+Extracellular+Vesicles+as+Potential+Biomarkers+for+Urologic+Cancers%3A+An+Overview+of+Current+Methods+and+Advances&rft.jtitle=Cancers&rft.au=Louren%C3%A7o%2C+Catarina&rft.au=Const%C3%A2ncio%2C+Vera&rft.au=Rui+Henrique&rft.au=Carvalho%2C+%C3%82ngela&rft.date=2021-03-26&rft.pub=MDPI+AG&rft.eissn=2072-6694&rft.volume=13&rft.issue=7&rft.spage=1529&rft_id=info:doi/10.3390%2Fcancers13071529&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon |